IDPN and IPN therapies are a go-to for effectively increasing patient albumin and prealbumin levels. But did you know they also offer a number of other well-documented and proven benefits? Studies show they can prevent weight loss, decrease mortality and malnutrition and increase appetite in patients. The below studies outline the wide array of benefits provided by IDPN and/or IPN therapy.
The following supporting anecdotal and empirical evidence may be used to supplement some of the evidence-based medical literature referenced above.
In the short term, some transplant patients on IDPN and IPN therapy were able to maintain stability. Surgeons are hesitant to operate on patients with low albumin levels. Patients may also experience a swifter recovery after their transplant procedure.
Some patients also showed improved fluid balance.
Higher IDPN osmolarity (1400-2000 mOsm/L) encourages 3rd space fluids to enter the vasculature, dialysis machines can then remove that fluids by challenging patients weight.
The therapies may also promote wound healing due to reduced Inflammation and improved availability of plasma proteins, such as Albumin, Globulins and Fibrinogen.
Patients also benefited from:
Improved strength, body composition & overall well-being, leading to an overall, improved better quality of life
Increased hemoglobin, reduced EPO resistance and EPO usage. This was evidenced by the reduction of inflammation marker Ferritin, and the patient’s ability to utilize Iron more efficiently.
Refer a Patient
Simply complete and submit PCA’s Referral Form and submit online or fax to 1-888-503-6982.
Our Patient Care Coordinators are also ready to assist you with referrals at 866-348-0441.